Should I get liquid biopsy or tissue biopsy for Desmoid Tumors

Liquid Biopsy vs. Tissue Biopsy for Desmoid Tumors

This is an important question, and I want to help you understand how these two approaches differ and what's typically recommended for desmoid tumors specifically.

Understanding the Two Approaches

Tissue Biopsy involves removing a small sample of the actual tumor itself for examination under a microscope. This is the traditional, gold-standard approach for diagnosing and understanding tumors.

Liquid Biopsy is a newer technology that analyzes cancer-related material (like circulating tumor DNA) found in your blood rather than requiring tissue removal.

What the Evidence Shows About Liquid Biopsy

According to the webinar "The BostonGene Tumor Portrait Report and How to Access It," there are important considerations with liquid biopsy testing:

• Variations in results: Different liquid biopsy tests using different gene panels and technologies can produce different findings in the same patient
• Accuracy challenges: Liquid biopsies can have both false positives (incorrectly suggesting something is present) and false negatives (missing something that is actually there)
• Ongoing refinement: Companies like BostonGene are working to address these challenges through improved filtering and validation methods

The Current Standard for Desmoid Tumors

For desmoid tumors specifically, tissue biopsy remains the standard diagnostic approach. Here's why:

1. Diagnosis confirmation: Desmoid tumors require tissue examination to confirm the diagnosis and rule out other conditions
2. Genetic testing: Tissue samples allow pathologists to identify the CTNNB1 mutation (present in ~85% of desmoid tumors), which is crucial for understanding your specific tumor
3. Prognostic information: Tissue analysis provides important details about tumor characteristics that guide treatment decisions

Questions to Ask Your Oncology Team

Since your specific situation requires your doctor's evaluation, here are key questions to discuss:

1. "Do you recommend tissue biopsy to confirm my desmoid tumor diagnosis and test for CTNNB1 mutations?"
2. "Could liquid biopsy be useful as a complementary tool to monitor my tumor during or after treatment?"
3. "Are there any reasons my specific case might benefit from liquid biopsy in addition to tissue testing?"
4. "How will the results from either test inform my treatment plan?"
5. "What are the risks and benefits of each approach for my particular situation?"

Important Context

Your oncologist will determine the most appropriate diagnostic approach for YOUR case based on your complete clinical picture, including whether tissue is already available from a previous biopsy or surgery, the location of your tumor, and your overall treatment plan.

Liquid biopsy technology is advancing rapidly and may play an increasingly important role in monitoring desmoid tumors over time, but tissue biopsy remains essential for initial diagnosis and characterization.

---

This information is for educational purposes only. Always consult your healthcare team for personalized medical advice and decisions.